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CASE REPORTCutaneous mucinosis of infancy
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250Key words: Alcian blue; cutaneous mucinosis of infancy; cobblestoned plaque; mucin.Fig 1. Flesh-colored cobblestone plaque seen on left
thigh. Healing biopsy site is visible near the center of the
lesion.
Abbreviations used:
CMI: cutaneous mucinosis of infancy
SHJCM: self-healing juvenile cutaneous mucinosisW
e present a case of a 4-year-old fair-
skinned girl, with no significant medical
history, who presented to the outpatient
clinic of an academic medical center with an asymp-
tomatic, flesh-colored, cobblestoned plaque on her
lateral left thigh (Fig 1). Per the family’s report, the
lesion had grown significantly since it was first
noticed 2 years ago, with current measurements of
7.5 cm by 6.5 cm at the time of clinical presentation.
The patient denied pain, tenderness, or pruritus at
the site, and there was no history of drainage or
infection. Further interrogation found no family
history of cutaneous malignancies and no history of
trauma to the area. The clinical differential diagnosis
included lymphangioma, granuloma annulare, and
scleromyxedema.
An incisional biopsy of the lesion was performed
after obtaining informed consent from the patient’s
mother. Sections showed increased mucin, high-
lighted by alcian blue stains, confined to the dermis.
The subcutis was normal (Fig 2). There was no
evidence of abnormal lymphatic pattern or intersti-
tial histiocytes. A diagnosis of cutaneous mucinosis
of infancy (CMI) was made. The patient and her
family were assured of the benign nature of CMI. She
will be monitored for any acute changes to the
lesion, but she is not being treated with any
pharmacologic intervention or further surgical action
at this point.
DISCUSSION
CMI was recognized as a distinct clinical entity in
1980.1 Since then, only 8 cases have been reported.2-5
The histologic appearance of CMI shares featureswith
other cutaneousmucinoses, including localized lichen
myxedematosus, papular lichenmyxedematosis, acralthe Department of Dermatology, University of Rochester
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chester.edu.persistentpapularmucinosis, and self-healing juvenile
cutaneous mucinosis (SHJCM). Unifying characteris-
tics of these conditions include the absence of thyroid
disease and the absence of rheumatologic disease.4,6
Given the rarity of CMI, there are currently insufficient
data to establish if CMI is in its own class of disease or
if it is simply a member of the pediatric papular
mucinosis family. The reported cases describe ageJAAD Case Reports 2016;2:250-2.
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Fig 2. Sections show a subtle thickening of the reticular dermis with widening of the interstitial
spaces, seen in low power (A) and high power (B). C, Alcian blue stains highlight the increased
mucin.
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traits in the disease, but there are hardly robust data
to establish diagnostic criteria.2
The clinical presentation of CMI and SHJCM are
distinctly different, which aids in discriminating
between these 2 mucinoses of infancy and child-
hood. Unlike SHJCM, mucin in CMI is confined to the
dermis, and there is no accompanying fibroblastic
proliferation.
CMI presents as a plaque or localized grouping of
papules in young children. The most common areas
for these localized lesions are the upper extremities
and trunk.4 Lesions on the thigh, as seen in our
patient, were similarly noted in a recent report.3
Nearly all cases are idiopathic, although the case of a
child whose father had similar cutaneous lesions
during his childhood may suggest a genetic or
multifactorial element.2 Even though our patient’s
lesions were first noticed at 2 years of age, other
lesions associated with CMI have presented at birth.5
Mucin, which is produced by fibroblasts and
normally accumulates in small quantities as part of
the skin’s extracellular matrix, is important in regu-
lating fluid balance and contributing to the extracel-
lular scaffold. For unclear reasons, patients with the
aforementioned mucinoses experience an abnormal
deposition of mucin, which results in clinically
appreciated cutaneous lesions.The abnormal deposition of mucin may be the
primary etiology of a cutaneous mucinosis, as in the
case of CMI. In addition, abnormal extracellular
mucin accumulation can be the result of a secondary
disease process in the context of a systemic condi-
tion. This finding is perhaps most widely recognized
in the findings of exophthalmos and pretibial
myxedema in the setting of Graves’ disease hyper-
thyroidism. In this scenario, autoantibodies induce
fibroblasts to produce and deposit glycosaminogly-
cans, a variant of mucin.7 Fibroblast overstimulation,
hypersensitivity reactions, viral infections, and
neoplastic changes are among the proposed mech-
anisms of cutaneous mucinoses.8,9 A working model
of the pathophysiologic mechanism of CMI has not
been proposed.
CMI has been classically considered a persistent,
stable cutaneous condition, although reports of
dynamic changes in its lesions, including the ex-
panding nature of our own patient’s lesion, highlight
our evolving understanding of this condition.3,4
Given their similar cutaneous findings and pathol-
ogy, CMI and SHJCM are considered related disorders.
Although mucin accumulation in the dermis is a
recognized phenomenon in both cases, the clinical
course differs between these diseases. The cutaneous
lesions in CMI are known to persist for many years. In
addition, CMI has not been shown to be associated
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ever, tend to present in older patients (most cases
present at age 8 years or older), are self-resolving, and
classically occur on the face or hands. In addition, the
cutaneous findings in SHJCM have been associated
with systemic symptoms such as arthralgias, myositis,
and lymphocytosis.10,11 Histologically, SHJCM has a
fibroblastic reactive proliferation involving the dermis
and subcutis, with mucin deposited throughout the
dermis and subcutis.
This patient’s presentation is particularly inter-
esting in that many of the lesion’s characteristics are
unusual for this disease, including the expanding
nature of the lesion and its location on the lower
extremity. We describe this patient’s case to highlight
the importance of recognizing this initially concern-
ing, yet ultimately benign, cutaneous lesion.REFERENCES
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